nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—ERBB3—schizophrenia	0.6	1	CbGaD
Vandetanib—Bosutinib—VRK2—schizophrenia	0.00261	0.259	CrCbGaD
Vandetanib—Afatinib—ERBB4—schizophrenia	0.00203	0.202	CrCbGaD
Vandetanib—FLT3—blood plasma—schizophrenia	0.00198	0.0127	CbGeAlD
Vandetanib—Bosutinib—FES—schizophrenia	0.00198	0.196	CrCbGaD
Vandetanib—FYN—blood plasma—schizophrenia	0.00148	0.00949	CbGeAlD
Vandetanib—STK10—blood plasma—schizophrenia	0.00133	0.00849	CbGeAlD
Vandetanib—SRC—blood plasma—schizophrenia	0.00129	0.00824	CbGeAlD
Vandetanib—EPHA5—forebrain—schizophrenia	0.00128	0.00818	CbGeAlD
Vandetanib—TYRO3—forebrain—schizophrenia	0.00128	0.00818	CbGeAlD
Vandetanib—KDR—blood plasma—schizophrenia	0.00118	0.00758	CbGeAlD
Vandetanib—EPHA5—telencephalon—schizophrenia	0.00117	0.00752	CbGeAlD
Vandetanib—TYRO3—telencephalon—schizophrenia	0.00117	0.00752	CbGeAlD
Vandetanib—BLK—blood—schizophrenia	0.00116	0.00746	CbGeAlD
Vandetanib—PTK6—blood—schizophrenia	0.0011	0.00707	CbGeAlD
Vandetanib—EPHA6—gonad—schizophrenia	0.00106	0.00677	CbGeAlD
Vandetanib—PLK4—gonad—schizophrenia	0.00104	0.00668	CbGeAlD
Vandetanib—TYRO3—gonad—schizophrenia	0.00098	0.00628	CbGeAlD
Vandetanib—FMO1—forebrain—schizophrenia	0.000973	0.00623	CbGeAlD
Vandetanib—PTK6—endocrine gland—schizophrenia	0.000957	0.00613	CbGeAlD
Vandetanib—ERBB3—forebrain—schizophrenia	0.000939	0.00601	CbGeAlD
Vandetanib—EGFR—telencephalon—schizophrenia	0.00093	0.00596	CbGeAlD
Vandetanib—PLK4—blood—schizophrenia	0.000909	0.00582	CbGeAlD
Vandetanib—VEGFA—telencephalon—schizophrenia	0.000899	0.00576	CbGeAlD
Vandetanib—EPHA8—nervous system—schizophrenia	0.000896	0.00574	CbGeAlD
Vandetanib—Bosutinib—ERBB4—schizophrenia	0.000884	0.0878	CrCbGaD
Vandetanib—ERBB3—telencephalon—schizophrenia	0.000863	0.00553	CbGeAlD
Vandetanib—EPHA8—central nervous system—schizophrenia	0.000863	0.00553	CbGeAlD
Vandetanib—LYN—blood—schizophrenia	0.00085	0.00544	CbGeAlD
Vandetanib—EPHA8—cerebellum—schizophrenia	0.000843	0.0054	CbGeAlD
Vandetanib—EPHA5—midbrain—schizophrenia	0.000843	0.0054	CbGeAlD
Vandetanib—FLT3—gonad—schizophrenia	0.000833	0.00534	CbGeAlD
Vandetanib—STK35—gonad—schizophrenia	0.000816	0.00523	CbGeAlD
Vandetanib—FYN—forebrain—schizophrenia	0.000812	0.0052	CbGeAlD
Vandetanib—MKNK1—telencephalon—schizophrenia	0.000811	0.00519	CbGeAlD
Vandetanib—EPHA6—endocrine gland—schizophrenia	0.000798	0.00511	CbGeAlD
Vandetanib—AXL—telencephalon—schizophrenia	0.000797	0.00511	CbGeAlD
Vandetanib—MAP4K5—forebrain—schizophrenia	0.000793	0.00508	CbGeAlD
Vandetanib—PLK4—endocrine gland—schizophrenia	0.000788	0.00505	CbGeAlD
Vandetanib—CYP3A4—urine—schizophrenia	0.000768	0.00492	CbGeAlD
Vandetanib—SLK—telencephalon—schizophrenia	0.000768	0.00492	CbGeAlD
Vandetanib—EPHB6—forebrain—schizophrenia	0.000758	0.00486	CbGeAlD
Vandetanib—EPHA6—nervous system—schizophrenia	0.000747	0.00479	CbGeAlD
Vandetanib—FYN—telencephalon—schizophrenia	0.000746	0.00478	CbGeAlD
Vandetanib—TYRO3—endocrine gland—schizophrenia	0.000741	0.00475	CbGeAlD
Vandetanib—EPHA5—endocrine gland—schizophrenia	0.000741	0.00475	CbGeAlD
Vandetanib—LYN—endocrine gland—schizophrenia	0.000737	0.00472	CbGeAlD
Vandetanib—TEK—telencephalon—schizophrenia	0.000729	0.00467	CbGeAlD
Vandetanib—MAP4K5—telencephalon—schizophrenia	0.000729	0.00467	CbGeAlD
Vandetanib—FLT3—blood—schizophrenia	0.000726	0.00465	CbGeAlD
Vandetanib—BMPR1B—endocrine gland—schizophrenia	0.000726	0.00465	CbGeAlD
Vandetanib—EPHA6—central nervous system—schizophrenia	0.000719	0.00461	CbGeAlD
Vandetanib—LTK—brain—schizophrenia	0.000714	0.00458	CbGeAlD
Vandetanib—SRC—forebrain—schizophrenia	0.000705	0.00451	CbGeAlD
Vandetanib—STK35—midbrain—schizophrenia	0.000702	0.0045	CbGeAlD
Vandetanib—Gefitinib—ERBB3—schizophrenia	0.000699	0.0694	CrCbGaD
Vandetanib—EPHB6—telencephalon—schizophrenia	0.000697	0.00447	CbGeAlD
Vandetanib—EPHA5—nervous system—schizophrenia	0.000693	0.00444	CbGeAlD
Vandetanib—TYRO3—nervous system—schizophrenia	0.000693	0.00444	CbGeAlD
Vandetanib—ABL2—blood—schizophrenia	0.000693	0.00444	CbGeAlD
Vandetanib—LYN—nervous system—schizophrenia	0.00069	0.00442	CbGeAlD
Vandetanib—Bosutinib—ERBB3—schizophrenia	0.000688	0.0684	CrCbGaD
Vandetanib—EPHA8—brain—schizophrenia	0.000685	0.00439	CbGeAlD
Vandetanib—BMPR1B—nervous system—schizophrenia	0.000679	0.00435	CbGeAlD
Vandetanib—MAP3K19—nervous system—schizophrenia	0.000679	0.00435	CbGeAlD
Vandetanib—MKNK1—gonad—schizophrenia	0.000676	0.00433	CbGeAlD
Vandetanib—YES1—telencephalon—schizophrenia	0.000674	0.00432	CbGeAlD
Vandetanib—EPHA5—central nervous system—schizophrenia	0.000667	0.00428	CbGeAlD
Vandetanib—TYRO3—central nervous system—schizophrenia	0.000667	0.00428	CbGeAlD
Vandetanib—AXL—gonad—schizophrenia	0.000666	0.00426	CbGeAlD
Vandetanib—LYN—central nervous system—schizophrenia	0.000664	0.00425	CbGeAlD
Vandetanib—FLT4—blood—schizophrenia	0.00066	0.00422	CbGeAlD
Vandetanib—RIPK2—blood—schizophrenia	0.000656	0.0042	CbGeAlD
Vandetanib—MAP3K19—central nervous system—schizophrenia	0.000654	0.00419	CbGeAlD
Vandetanib—BMPR1B—central nervous system—schizophrenia	0.000654	0.00419	CbGeAlD
Vandetanib—EPHA5—cerebellum—schizophrenia	0.000652	0.00418	CbGeAlD
Vandetanib—TYRO3—cerebellum—schizophrenia	0.000652	0.00418	CbGeAlD
Vandetanib—KDR—forebrain—schizophrenia	0.000648	0.00415	CbGeAlD
Vandetanib—SRC—telencephalon—schizophrenia	0.000648	0.00415	CbGeAlD
Vandetanib—RIPK2—midbrain—schizophrenia	0.000648	0.00415	CbGeAlD
Vandetanib—IRAK4—blood—schizophrenia	0.00064	0.0041	CbGeAlD
Vandetanib—BMPR1B—cerebellum—schizophrenia	0.000639	0.00409	CbGeAlD
Vandetanib—FLT3—endocrine gland—schizophrenia	0.00063	0.00403	CbGeAlD
Vandetanib—ERBB3—midbrain—schizophrenia	0.00062	0.00397	CbGeAlD
Vandetanib—STK35—endocrine gland—schizophrenia	0.000617	0.00395	CbGeAlD
Vandetanib—MAP4K5—gonad—schizophrenia	0.000609	0.0039	CbGeAlD
Vandetanib—MAP2K5—telencephalon—schizophrenia	0.000596	0.00382	CbGeAlD
Vandetanib—MKNK1—blood—schizophrenia	0.000589	0.00378	CbGeAlD
Vandetanib—LCK—blood—schizophrenia	0.000582	0.00373	CbGeAlD
Vandetanib—RET—blood—schizophrenia	0.000582	0.00373	CbGeAlD
Vandetanib—FGR—blood—schizophrenia	0.000582	0.00373	CbGeAlD
Vandetanib—MKNK1—midbrain—schizophrenia	0.000582	0.00373	CbGeAlD
Vandetanib—STK35—nervous system—schizophrenia	0.000577	0.0037	CbGeAlD
Vandetanib—RET—midbrain—schizophrenia	0.000575	0.00368	CbGeAlD
Vandetanib—AXL—midbrain—schizophrenia	0.000573	0.00367	CbGeAlD
Vandetanib—FLT4—endocrine gland—schizophrenia	0.000572	0.00366	CbGeAlD
Vandetanib—EPHA6—brain—schizophrenia	0.000571	0.00366	CbGeAlD
Vandetanib—RIPK2—endocrine gland—schizophrenia	0.000569	0.00364	CbGeAlD
Vandetanib—FMO1—endocrine gland—schizophrenia	0.000564	0.00362	CbGeAlD
Vandetanib—PLK4—brain—schizophrenia	0.000564	0.00361	CbGeAlD
Vandetanib—YES1—gonad—schizophrenia	0.000562	0.0036	CbGeAlD
Vandetanib—SLK—blood—schizophrenia	0.000558	0.00358	CbGeAlD
Vandetanib—STK10—gonad—schizophrenia	0.000557	0.00357	CbGeAlD
Vandetanib—STK35—central nervous system—schizophrenia	0.000556	0.00356	CbGeAlD
Vandetanib—FLT3—cerebellum—schizophrenia	0.000555	0.00355	CbGeAlD
Vandetanib—SLK—midbrain—schizophrenia	0.000551	0.00353	CbGeAlD
Vandetanib—ERBB3—endocrine gland—schizophrenia	0.000545	0.00349	CbGeAlD
Vandetanib—STK35—cerebellum—schizophrenia	0.000543	0.00348	CbGeAlD
Vandetanib—FYN—blood—schizophrenia	0.000543	0.00348	CbGeAlD
Vandetanib—SRC—gonad—schizophrenia	0.000541	0.00346	CbGeAlD
Vandetanib—FYN—midbrain—schizophrenia	0.000536	0.00343	CbGeAlD
Vandetanib—MAP4K5—blood—schizophrenia	0.00053	0.0034	CbGeAlD
Vandetanib—TEK—blood—schizophrenia	0.00053	0.0034	CbGeAlD
Vandetanib—TYRO3—brain—schizophrenia	0.00053	0.00339	CbGeAlD
Vandetanib—EPHA5—brain—schizophrenia	0.00053	0.00339	CbGeAlD
Vandetanib—ABL2—cerebellum—schizophrenia	0.00053	0.00339	CbGeAlD
Vandetanib—FMO1—nervous system—schizophrenia	0.000528	0.00338	CbGeAlD
Vandetanib—LYN—brain—schizophrenia	0.000527	0.00338	CbGeAlD
Vandetanib—TEK—midbrain—schizophrenia	0.000524	0.00336	CbGeAlD
Vandetanib—MAP4K5—midbrain—schizophrenia	0.000524	0.00336	CbGeAlD
Vandetanib—IRAK4—nervous system—schizophrenia	0.00052	0.00333	CbGeAlD
Vandetanib—BMPR1B—brain—schizophrenia	0.000519	0.00333	CbGeAlD
Vandetanib—MAP3K19—brain—schizophrenia	0.000519	0.00333	CbGeAlD
Vandetanib—EGFR—cerebellum—schizophrenia	0.000517	0.00331	CbGeAlD
Vandetanib—PDGFRB—telencephalon—schizophrenia	0.000516	0.00331	CbGeAlD
Vandetanib—MKNK1—endocrine gland—schizophrenia	0.000511	0.00328	CbGeAlD
Vandetanib—ERBB3—nervous system—schizophrenia	0.00051	0.00327	CbGeAlD
Vandetanib—FMO1—central nervous system—schizophrenia	0.000509	0.00326	CbGeAlD
Vandetanib—EPHB6—blood—schizophrenia	0.000507	0.00325	CbGeAlD
Vandetanib—FGR—endocrine gland—schizophrenia	0.000505	0.00324	CbGeAlD
Vandetanib—RET—endocrine gland—schizophrenia	0.000505	0.00324	CbGeAlD
Vandetanib—AXL—endocrine gland—schizophrenia	0.000503	0.00322	CbGeAlD
Vandetanib—RIPK2—cerebellum—schizophrenia	0.000501	0.00321	CbGeAlD
Vandetanib—IRAK4—central nervous system—schizophrenia	0.000501	0.00321	CbGeAlD
Vandetanib—EPHB6—midbrain—schizophrenia	0.000501	0.00321	CbGeAlD
Vandetanib—VEGFA—cerebellum—schizophrenia	0.0005	0.0032	CbGeAlD
Vandetanib—ERBB3—central nervous system—schizophrenia	0.000491	0.00314	CbGeAlD
Vandetanib—YES1—blood—schizophrenia	0.00049	0.00314	CbGeAlD
Vandetanib—IRAK4—cerebellum—schizophrenia	0.000489	0.00313	CbGeAlD
Vandetanib—FMO3—endocrine gland—schizophrenia	0.000488	0.00312	CbGeAlD
Vandetanib—STK10—blood—schizophrenia	0.000485	0.00311	CbGeAlD
Vandetanib—YES1—midbrain—schizophrenia	0.000484	0.0031	CbGeAlD
Vandetanib—ERBB3—cerebellum—schizophrenia	0.00048	0.00307	CbGeAlD
Vandetanib—MKNK1—nervous system—schizophrenia	0.000479	0.00307	CbGeAlD
Vandetanib—FGR—nervous system—schizophrenia	0.000473	0.00303	CbGeAlD
Vandetanib—RET—nervous system—schizophrenia	0.000473	0.00303	CbGeAlD
Vandetanib—SRC—blood—schizophrenia	0.000471	0.00302	CbGeAlD
Vandetanib—AXL—nervous system—schizophrenia	0.000471	0.00302	CbGeAlD
Vandetanib—FYN—endocrine gland—schizophrenia	0.000471	0.00302	CbGeAlD
Vandetanib—MKNK1—central nervous system—schizophrenia	0.000461	0.00295	CbGeAlD
Vandetanib—TEK—endocrine gland—schizophrenia	0.00046	0.00295	CbGeAlD
Vandetanib—MAP4K5—endocrine gland—schizophrenia	0.00046	0.00295	CbGeAlD
Vandetanib—ABL1—telencephalon—schizophrenia	0.00046	0.00295	CbGeAlD
Vandetanib—FMO3—nervous system—schizophrenia	0.000456	0.00292	CbGeAlD
Vandetanib—FGR—central nervous system—schizophrenia	0.000455	0.00292	CbGeAlD
Vandetanib—RET—central nervous system—schizophrenia	0.000455	0.00292	CbGeAlD
Vandetanib—AXL—central nervous system—schizophrenia	0.000453	0.0029	CbGeAlD
Vandetanib—MKNK1—cerebellum—schizophrenia	0.00045	0.00288	CbGeAlD
Vandetanib—RET—cerebellum—schizophrenia	0.000445	0.00285	CbGeAlD
Vandetanib—AXL—cerebellum—schizophrenia	0.000443	0.00284	CbGeAlD
Vandetanib—STK35—brain—schizophrenia	0.000441	0.00283	CbGeAlD
Vandetanib—FYN—nervous system—schizophrenia	0.000441	0.00282	CbGeAlD
Vandetanib—FMO3—central nervous system—schizophrenia	0.00044	0.00282	CbGeAlD
Vandetanib—MAP2K5—blood—schizophrenia	0.000433	0.00278	CbGeAlD
Vandetanib—KDR—blood—schizophrenia	0.000433	0.00278	CbGeAlD
Vandetanib—PDGFRB—gonad—schizophrenia	0.000431	0.00276	CbGeAlD
Vandetanib—MAP4K5—nervous system—schizophrenia	0.000431	0.00276	CbGeAlD
Vandetanib—TEK—nervous system—schizophrenia	0.000431	0.00276	CbGeAlD
Vandetanib—ABL2—brain—schizophrenia	0.00043	0.00276	CbGeAlD
Vandetanib—MAP2K5—midbrain—schizophrenia	0.000428	0.00274	CbGeAlD
Vandetanib—KDR—midbrain—schizophrenia	0.000428	0.00274	CbGeAlD
Vandetanib—SLK—cerebellum—schizophrenia	0.000426	0.00273	CbGeAlD
Vandetanib—YES1—endocrine gland—schizophrenia	0.000425	0.00272	CbGeAlD
Vandetanib—FYN—central nervous system—schizophrenia	0.000424	0.00272	CbGeAlD
Vandetanib—STK10—endocrine gland—schizophrenia	0.000421	0.0027	CbGeAlD
Vandetanib—EGFR—brain—schizophrenia	0.00042	0.00269	CbGeAlD
Vandetanib—FYN—cerebellum—schizophrenia	0.000415	0.00266	CbGeAlD
Vandetanib—TEK—central nervous system—schizophrenia	0.000415	0.00266	CbGeAlD
Vandetanib—MAP4K5—central nervous system—schizophrenia	0.000415	0.00266	CbGeAlD
Vandetanib—EPHB6—nervous system—schizophrenia	0.000411	0.00264	CbGeAlD
Vandetanib—FLT4—brain—schizophrenia	0.000409	0.00262	CbGeAlD
Vandetanib—SRC—endocrine gland—schizophrenia	0.000409	0.00262	CbGeAlD
Vandetanib—RIPK2—brain—schizophrenia	0.000407	0.00261	CbGeAlD
Vandetanib—VEGFA—brain—schizophrenia	0.000406	0.0026	CbGeAlD
Vandetanib—TEK—cerebellum—schizophrenia	0.000405	0.0026	CbGeAlD
Vandetanib—MAP4K5—cerebellum—schizophrenia	0.000405	0.0026	CbGeAlD
Vandetanib—FMO1—brain—schizophrenia	0.000404	0.00259	CbGeAlD
Vandetanib—CYP3A4—blood plasma—schizophrenia	0.000401	0.00257	CbGeAlD
Vandetanib—YES1—nervous system—schizophrenia	0.000398	0.00255	CbGeAlD
Vandetanib—IRAK4—brain—schizophrenia	0.000397	0.00255	CbGeAlD
Vandetanib—EPHB6—central nervous system—schizophrenia	0.000396	0.00254	CbGeAlD
Vandetanib—STK10—nervous system—schizophrenia	0.000394	0.00252	CbGeAlD
Vandetanib—ERBB3—brain—schizophrenia	0.00039	0.0025	CbGeAlD
Vandetanib—EPHB6—cerebellum—schizophrenia	0.000387	0.00248	CbGeAlD
Vandetanib—ABL1—gonad—schizophrenia	0.000384	0.00246	CbGeAlD
Vandetanib—YES1—central nervous system—schizophrenia	0.000383	0.00245	CbGeAlD
Vandetanib—SRC—nervous system—schizophrenia	0.000383	0.00245	CbGeAlD
Vandetanib—STK10—central nervous system—schizophrenia	0.000379	0.00243	CbGeAlD
Vandetanib—MAP2K5—endocrine gland—schizophrenia	0.000376	0.00241	CbGeAlD
Vandetanib—KDR—endocrine gland—schizophrenia	0.000376	0.00241	CbGeAlD
Vandetanib—PDGFRB—blood—schizophrenia	0.000375	0.0024	CbGeAlD
Vandetanib—YES1—cerebellum—schizophrenia	0.000374	0.0024	CbGeAlD
Vandetanib—STK10—cerebellum—schizophrenia	0.000371	0.00238	CbGeAlD
Vandetanib—PDGFRB—midbrain—schizophrenia	0.00037	0.00237	CbGeAlD
Vandetanib—SRC—central nervous system—schizophrenia	0.000368	0.00236	CbGeAlD
Vandetanib—MKNK1—brain—schizophrenia	0.000366	0.00234	CbGeAlD
Vandetanib—RET—brain—schizophrenia	0.000361	0.00231	CbGeAlD
Vandetanib—FGR—brain—schizophrenia	0.000361	0.00231	CbGeAlD
Vandetanib—SRC—cerebellum—schizophrenia	0.00036	0.00231	CbGeAlD
Vandetanib—AXL—brain—schizophrenia	0.00036	0.00231	CbGeAlD
Vandetanib—ORM1—blood—schizophrenia	0.000352	0.00225	CbGeAlD
Vandetanib—KDR—nervous system—schizophrenia	0.000352	0.00225	CbGeAlD
Vandetanib—MAP2K5—nervous system—schizophrenia	0.000352	0.00225	CbGeAlD
Vandetanib—ABCC1—telencephalon—schizophrenia	0.00035	0.00224	CbGeAlD
Vandetanib—FMO3—brain—schizophrenia	0.000349	0.00224	CbGeAlD
Vandetanib—SLK—brain—schizophrenia	0.000346	0.00222	CbGeAlD
Vandetanib—MAP2K5—central nervous system—schizophrenia	0.000339	0.00217	CbGeAlD
Vandetanib—KDR—central nervous system—schizophrenia	0.000339	0.00217	CbGeAlD
Vandetanib—FYN—brain—schizophrenia	0.000337	0.00216	CbGeAlD
Vandetanib—ABL1—blood—schizophrenia	0.000334	0.00214	CbGeAlD
Vandetanib—MAP2K5—cerebellum—schizophrenia	0.000331	0.00212	CbGeAlD
Vandetanib—KDR—cerebellum—schizophrenia	0.000331	0.00212	CbGeAlD
Vandetanib—ABL1—midbrain—schizophrenia	0.00033	0.00212	CbGeAlD
Vandetanib—MAP4K5—brain—schizophrenia	0.000329	0.00211	CbGeAlD
Vandetanib—TEK—brain—schizophrenia	0.000329	0.00211	CbGeAlD
Vandetanib—PDGFRB—endocrine gland—schizophrenia	0.000325	0.00208	CbGeAlD
Vandetanib—EPHB6—brain—schizophrenia	0.000315	0.00201	CbGeAlD
Vandetanib—ORM1—endocrine gland—schizophrenia	0.000305	0.00196	CbGeAlD
Vandetanib—PDGFRB—nervous system—schizophrenia	0.000305	0.00195	CbGeAlD
Vandetanib—YES1—brain—schizophrenia	0.000304	0.00195	CbGeAlD
Vandetanib—STK10—brain—schizophrenia	0.000301	0.00193	CbGeAlD
Vandetanib—PDGFRB—central nervous system—schizophrenia	0.000293	0.00188	CbGeAlD
Vandetanib—SRC—brain—schizophrenia	0.000292	0.00187	CbGeAlD
Vandetanib—ABL1—endocrine gland—schizophrenia	0.00029	0.00186	CbGeAlD
Vandetanib—ABCG2—telencephalon—schizophrenia	0.00029	0.00186	CbGeAlD
Vandetanib—PDGFRB—cerebellum—schizophrenia	0.000287	0.00184	CbGeAlD
Vandetanib—ORM1—nervous system—schizophrenia	0.000286	0.00183	CbGeAlD
Vandetanib—Erlotinib—CYP1A2—schizophrenia	0.000276	0.0274	CrCbGaD
Vandetanib—ORM1—central nervous system—schizophrenia	0.000275	0.00176	CbGeAlD
Vandetanib—ABL1—nervous system—schizophrenia	0.000271	0.00174	CbGeAlD
Vandetanib—KDR—brain—schizophrenia	0.000269	0.00172	CbGeAlD
Vandetanib—MAP2K5—brain—schizophrenia	0.000269	0.00172	CbGeAlD
Vandetanib—ABL1—central nervous system—schizophrenia	0.000261	0.00167	CbGeAlD
Vandetanib—ABL1—cerebellum—schizophrenia	0.000255	0.00164	CbGeAlD
Vandetanib—ABCC1—blood—schizophrenia	0.000255	0.00163	CbGeAlD
Vandetanib—PDGFRB—brain—schizophrenia	0.000233	0.00149	CbGeAlD
Vandetanib—Afatinib—ABCB1—schizophrenia	0.000216	0.0214	CrCbGaD
Vandetanib—Erlotinib—CYP2D6—schizophrenia	0.000213	0.0212	CrCbGaD
Vandetanib—ABCG2—blood—schizophrenia	0.000211	0.00135	CbGeAlD
Vandetanib—ABCG2—midbrain—schizophrenia	0.000208	0.00133	CbGeAlD
Vandetanib—ABL1—brain—schizophrenia	0.000208	0.00133	CbGeAlD
Vandetanib—ABCC1—cerebellum—schizophrenia	0.000195	0.00125	CbGeAlD
Vandetanib—ALB—brain—schizophrenia	0.000191	0.00123	CbGeAlD
Vandetanib—ABCG2—cerebellum—schizophrenia	0.000161	0.00103	CbGeAlD
Vandetanib—ABCC1—brain—schizophrenia	0.000158	0.00101	CbGeAlD
Vandetanib—Erlotinib—ABCB1—schizophrenia	0.000152	0.0151	CrCbGaD
Vandetanib—CYP3A4—blood—schizophrenia	0.000147	0.000941	CbGeAlD
Vandetanib—Gefitinib—CYP2D6—schizophrenia	0.000133	0.0133	CrCbGaD
Vandetanib—ABCG2—brain—schizophrenia	0.000131	0.000838	CbGeAlD
Vandetanib—CYP3A4—endocrine gland—schizophrenia	0.000127	0.000816	CbGeAlD
Vandetanib—CYP3A4—nervous system—schizophrenia	0.000119	0.000764	CbGeAlD
Vandetanib—CYP3A4—central nervous system—schizophrenia	0.000115	0.000736	CbGeAlD
Vandetanib—Gefitinib—ABCB1—schizophrenia	9.53e-05	0.00947	CrCbGaD
Vandetanib—Bosutinib—ABCB1—schizophrenia	9.38e-05	0.00932	CrCbGaD
Vandetanib—BMPR1B—Signaling Pathways—AKT1—schizophrenia	4.33e-06	1.85e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—APOE—schizophrenia	4.33e-06	1.85e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—YWHAZ—schizophrenia	4.32e-06	1.85e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MEF2C—schizophrenia	4.3e-06	1.84e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—AKT1—schizophrenia	4.3e-06	1.84e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—GSK3B—schizophrenia	4.29e-06	1.84e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—MTHFR—schizophrenia	4.29e-06	1.84e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—ERBB3—schizophrenia	4.28e-06	1.83e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—APOA1—schizophrenia	4.28e-06	1.83e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—GSTM1—schizophrenia	4.27e-06	1.83e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PLA2G4A—schizophrenia	4.27e-06	1.83e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—S100B—schizophrenia	4.25e-06	1.82e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PIK3C2A—schizophrenia	4.24e-06	1.81e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—YWHAZ—schizophrenia	4.22e-06	1.81e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CNR1—schizophrenia	4.22e-06	1.81e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—ERBB3—schizophrenia	4.22e-06	1.81e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—GSK3B—schizophrenia	4.21e-06	1.8e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PIP4K2A—schizophrenia	4.2e-06	1.8e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—FOS—schizophrenia	4.19e-06	1.79e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—YWHAZ—schizophrenia	4.16e-06	1.78e-05	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—AKT1—schizophrenia	4.14e-06	1.77e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—ERBB3—schizophrenia	4.13e-06	1.77e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—GSK3B—schizophrenia	4.13e-06	1.77e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—DRD2—schizophrenia	4.12e-06	1.76e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—HTR7—schizophrenia	4.12e-06	1.76e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—MTHFR—schizophrenia	4.12e-06	1.76e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—S100B—schizophrenia	4.1e-06	1.75e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—ERBB3—schizophrenia	4.07e-06	1.74e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—ERBB4—schizophrenia	4.07e-06	1.74e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—HTR2A—schizophrenia	4.06e-06	1.74e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—EP300—schizophrenia	4.06e-06	1.74e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—GSK3B—schizophrenia	4.06e-06	1.74e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—FOS—schizophrenia	4.03e-06	1.73e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—APOE—schizophrenia	3.99e-06	1.71e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—HTR2A—schizophrenia	3.98e-06	1.7e-05	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—AKT1—schizophrenia	3.96e-06	1.7e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—APOA1—schizophrenia	3.94e-06	1.69e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—ERBB4—schizophrenia	3.92e-06	1.68e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—HTR2A—schizophrenia	3.92e-06	1.68e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PRL—schizophrenia	3.89e-06	1.67e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—GSK3B—schizophrenia	3.89e-06	1.67e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—TP53—schizophrenia	3.89e-06	1.66e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—APOE—schizophrenia	3.83e-06	1.64e-05	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—AKT1—schizophrenia	3.83e-06	1.64e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PLA2G4A—schizophrenia	3.82e-06	1.64e-05	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—AKT1—schizophrenia	3.81e-06	1.63e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CYP2D6—schizophrenia	3.8e-06	1.63e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—SNAP25—schizophrenia	3.8e-06	1.63e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP26B1—schizophrenia	3.8e-06	1.63e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—APOA1—schizophrenia	3.79e-06	1.62e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—APOE—schizophrenia	3.78e-06	1.62e-05	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—AKT1—schizophrenia	3.77e-06	1.62e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—MTHFR—schizophrenia	3.77e-06	1.61e-05	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—AKT1—schizophrenia	3.77e-06	1.61e-05	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—AKT1—schizophrenia	3.76e-06	1.61e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NRG1—schizophrenia	3.75e-06	1.61e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—GSK3B—schizophrenia	3.75e-06	1.6e-05	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—AKT1—schizophrenia	3.74e-06	1.6e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—APOA1—schizophrenia	3.73e-06	1.6e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—TNF—schizophrenia	3.73e-06	1.6e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL1B—schizophrenia	3.72e-06	1.59e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MEF2C—schizophrenia	3.72e-06	1.59e-05	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—AKT1—schizophrenia	3.7e-06	1.58e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—APOE—schizophrenia	3.7e-06	1.58e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PLA2G4A—schizophrenia	3.68e-06	1.58e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—APOA1—schizophrenia	3.65e-06	1.56e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—EP300—schizophrenia	3.65e-06	1.56e-05	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—TP53—schizophrenia	3.65e-06	1.56e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL1B—schizophrenia	3.65e-06	1.56e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—APOE—schizophrenia	3.64e-06	1.56e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL1B—schizophrenia	3.63e-06	1.55e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—S100B—schizophrenia	3.63e-06	1.55e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NRG1—schizophrenia	3.62e-06	1.55e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—ESR1—schizophrenia	3.61e-06	1.54e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—APOA1—schizophrenia	3.6e-06	1.54e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—GSK3B—schizophrenia	3.59e-06	1.54e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—YWHAZ—schizophrenia	3.59e-06	1.54e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL1B—schizophrenia	3.59e-06	1.54e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MEF2C—schizophrenia	3.58e-06	1.53e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—FOS—schizophrenia	3.57e-06	1.53e-05	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—AKT1—schizophrenia	3.57e-06	1.53e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—ESR1—schizophrenia	3.53e-06	1.51e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—ERBB3—schizophrenia	3.51e-06	1.5e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—APOE—schizophrenia	3.51e-06	1.5e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—ESR1—schizophrenia	3.48e-06	1.49e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—APOA1—schizophrenia	3.47e-06	1.49e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—ERBB4—schizophrenia	3.47e-06	1.48e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—YWHAZ—schizophrenia	3.46e-06	1.48e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—AKT1—schizophrenia	3.45e-06	1.48e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CYP1A2—schizophrenia	3.44e-06	1.47e-05	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—AKT1—schizophrenia	3.41e-06	1.46e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—ERBB3—schizophrenia	3.39e-06	1.45e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—TH—schizophrenia	3.39e-06	1.45e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GCLM—schizophrenia	3.38e-06	1.45e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TPH1—schizophrenia	3.38e-06	1.45e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—HTR2A—schizophrenia	3.38e-06	1.45e-05	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—AKT1—schizophrenia	3.38e-06	1.45e-05	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—AKT1—schizophrenia	3.37e-06	1.44e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—EP300—schizophrenia	3.34e-06	1.43e-05	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—AKT1—schizophrenia	3.33e-06	1.43e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—EP300—schizophrenia	3.33e-06	1.43e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—GSK3B—schizophrenia	3.32e-06	1.42e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—AKT1—schizophrenia	3.32e-06	1.42e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—AKT1—schizophrenia	3.28e-06	1.41e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—AKT1—schizophrenia	3.28e-06	1.41e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—AKT1—schizophrenia	3.27e-06	1.4e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—GSK3B—schizophrenia	3.27e-06	1.4e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PLA2G4A—schizophrenia	3.26e-06	1.4e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—HTR2A—schizophrenia	3.26e-06	1.4e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—EP300—schizophrenia	3.26e-06	1.4e-05	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—AKT1—schizophrenia	3.26e-06	1.39e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—EP300—schizophrenia	3.25e-06	1.39e-05	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—AKT1—schizophrenia	3.25e-06	1.39e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—EP300—schizophrenia	3.24e-06	1.39e-05	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—TP53—schizophrenia	3.23e-06	1.38e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—EP300—schizophrenia	3.22e-06	1.38e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—EP300—schizophrenia	3.21e-06	1.37e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—GSK3B—schizophrenia	3.2e-06	1.37e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NRG1—schizophrenia	3.2e-06	1.37e-05	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—AKT1—schizophrenia	3.2e-06	1.37e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PRKD1—schizophrenia	3.18e-06	1.36e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MEF2C—schizophrenia	3.17e-06	1.36e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—GSK3B—schizophrenia	3.15e-06	1.35e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APOE—schizophrenia	3.14e-06	1.35e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APOA1—schizophrenia	3.11e-06	1.33e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL1B—schizophrenia	3.1e-06	1.33e-05	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—AKT1—schizophrenia	3.08e-06	1.32e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—EP300—schizophrenia	3.07e-06	1.32e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—YWHAZ—schizophrenia	3.07e-06	1.31e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—EP300—schizophrenia	3.05e-06	1.3e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APOE—schizophrenia	3.03e-06	1.3e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—AKT1—schizophrenia	3.01e-06	1.29e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—ESR1—schizophrenia	3e-06	1.29e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—ERBB3—schizophrenia	3e-06	1.28e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APOA1—schizophrenia	3e-06	1.28e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL1B—schizophrenia	2.99e-06	1.28e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—EP300—schizophrenia	2.96e-06	1.27e-05	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—AKT1—schizophrenia	2.96e-06	1.27e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—EP300—schizophrenia	2.93e-06	1.25e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—ESR1—schizophrenia	2.89e-06	1.24e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—HTR2A—schizophrenia	2.89e-06	1.24e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—COMT—schizophrenia	2.88e-06	1.23e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—AKT1—schizophrenia	2.88e-06	1.23e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GSTP1—schizophrenia	2.87e-06	1.23e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—MAOA—schizophrenia	2.86e-06	1.22e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—EP300—schizophrenia	2.83e-06	1.21e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—AKT1—schizophrenia	2.78e-06	1.19e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—AKT1—schizophrenia	2.78e-06	1.19e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.77e-06	1.19e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—EP300—schizophrenia	2.77e-06	1.19e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—AKT1—schizophrenia	2.77e-06	1.19e-05	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—AKT1—schizophrenia	2.76e-06	1.18e-05	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—AKT1—schizophrenia	2.73e-06	1.17e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—GSK3B—schizophrenia	2.72e-06	1.17e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—EP300—schizophrenia	2.72e-06	1.16e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—ABCB1—schizophrenia	2.71e-06	1.16e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APOE—schizophrenia	2.68e-06	1.15e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—EP300—schizophrenia	2.67e-06	1.14e-05	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—AKT1—schizophrenia	2.66e-06	1.14e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GAPDH—schizophrenia	2.66e-06	1.14e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APOA1—schizophrenia	2.65e-06	1.14e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL1B—schizophrenia	2.65e-06	1.13e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—AKT1—schizophrenia	2.64e-06	1.13e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GSTM1—schizophrenia	2.63e-06	1.13e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PLA2G4A—schizophrenia	2.63e-06	1.13e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CLOCK—schizophrenia	2.63e-06	1.13e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—GSK3B—schizophrenia	2.62e-06	1.12e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TP53—schizophrenia	2.61e-06	1.12e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TPH2—schizophrenia	2.57e-06	1.1e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CACNB2—schizophrenia	2.57e-06	1.1e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—ESR1—schizophrenia	2.56e-06	1.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—EP300—schizophrenia	2.56e-06	1.1e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—DPYD—schizophrenia	2.52e-06	1.08e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—EP300—schizophrenia	2.47e-06	1.06e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—AKT1—schizophrenia	2.45e-06	1.05e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TP53—schizophrenia	2.39e-06	1.02e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—EP300—schizophrenia	2.36e-06	1.01e-05	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—AKT1—schizophrenia	2.36e-06	1.01e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CACNA1C—schizophrenia	2.35e-06	1e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TP53—schizophrenia	2.33e-06	9.97e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—MTHFR—schizophrenia	2.33e-06	9.96e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—GSK3B—schizophrenia	2.32e-06	9.95e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TP53—schizophrenia	2.3e-06	9.86e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	2.29e-06	9.79e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—EP300—schizophrenia	2.27e-06	9.74e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—AKT1—schizophrenia	2.21e-06	9.45e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—EP300—schizophrenia	2.18e-06	9.35e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TP53—schizophrenia	2.18e-06	9.33e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOE—schizophrenia	2.17e-06	9.28e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—EP300—schizophrenia	2.15e-06	9.21e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOA1—schizophrenia	2.14e-06	9.17e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—EP300—schizophrenia	2.11e-06	9.02e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TP53—schizophrenia	2.09e-06	8.96e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—EP300—schizophrenia	2.07e-06	8.88e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP2D6—schizophrenia	2.05e-06	8.78e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SNAP25—schizophrenia	2.05e-06	8.78e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TP53—schizophrenia	2.02e-06	8.66e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—AKT1—schizophrenia	2.02e-06	8.64e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—AKT1—schizophrenia	2.01e-06	8.61e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—EP300—schizophrenia	2e-06	8.57e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—AKT1—schizophrenia	1.97e-06	8.43e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—AKT1—schizophrenia	1.97e-06	8.42e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—AKT1—schizophrenia	1.96e-06	8.39e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—AKT1—schizophrenia	1.95e-06	8.33e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—AKT1—schizophrenia	1.94e-06	8.3e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—AKT1—schizophrenia	1.86e-06	7.95e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP1A2—schizophrenia	1.85e-06	7.94e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—AKT1—schizophrenia	1.84e-06	7.88e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—AKT1—schizophrenia	1.83e-06	7.85e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TH—schizophrenia	1.83e-06	7.83e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—EP300—schizophrenia	1.79e-06	7.67e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—AKT1—schizophrenia	1.79e-06	7.66e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—AKT1—schizophrenia	1.77e-06	7.57e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—EP300—schizophrenia	1.73e-06	7.39e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—AKT1—schizophrenia	1.71e-06	7.31e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—AKT1—schizophrenia	1.68e-06	7.17e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—AKT1—schizophrenia	1.64e-06	7.03e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—AKT1—schizophrenia	1.61e-06	6.91e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—COMT—schizophrenia	1.55e-06	6.65e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GSTP1—schizophrenia	1.55e-06	6.62e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—AKT1—schizophrenia	1.55e-06	6.62e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MAOA—schizophrenia	1.54e-06	6.61e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TP53—schizophrenia	1.54e-06	6.59e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—EP300—schizophrenia	1.53e-06	6.55e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TP53—schizophrenia	1.51e-06	6.46e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—AKT1—schizophrenia	1.49e-06	6.38e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TP53—schizophrenia	1.48e-06	6.36e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ABCB1—schizophrenia	1.46e-06	6.27e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—AKT1—schizophrenia	1.43e-06	6.12e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	1.42e-06	6.09e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GSTM1—schizophrenia	1.42e-06	6.09e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—AKT1—schizophrenia	1.37e-06	5.88e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—AKT1—schizophrenia	1.32e-06	5.65e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—AKT1—schizophrenia	1.3e-06	5.57e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TP53—schizophrenia	1.28e-06	5.49e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—AKT1—schizophrenia	1.27e-06	5.45e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MTHFR—schizophrenia	1.26e-06	5.38e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—AKT1—schizophrenia	1.25e-06	5.37e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TP53—schizophrenia	1.24e-06	5.29e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—EP300—schizophrenia	1.23e-06	5.29e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—AKT1—schizophrenia	1.21e-06	5.18e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOE—schizophrenia	1.17e-06	5.01e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOA1—schizophrenia	1.16e-06	4.95e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TP53—schizophrenia	1.09e-06	4.68e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—AKT1—schizophrenia	1.08e-06	4.64e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—AKT1—schizophrenia	1.04e-06	4.47e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—AKT1—schizophrenia	9.24e-07	3.96e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—AKT1—schizophrenia	7.46e-07	3.19e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—EP300—schizophrenia	6.66e-07	2.85e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—AKT1—schizophrenia	4.03e-07	1.72e-06	CbGpPWpGaD
